Tumores neuroendocrinos: impacto de LANREÓTIDA en la supervivencia de la enfermedad estable y progresiva - page 19

Integrating pre-treatment kinetics

Hypothetical case #2 of a slow-growing tumour treated by an inactive drug

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,9,10,11,12,13,14,15,16,17,18 20,21,22,23,24,25,26